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Case reports are a valuable though oft-underestimated source of clinical knowledge, even
wisdom. They are extremely valuable to clinicians faced with new diseases, new investiga-
tions, and new therapies, where they provide the initial information, which serves as a basis
to plan a detailed comparative study to provide deﬁnitive answers. The publication of cases
and images-related reports is undoubtedly a gain for all, including medical students,
medical teachers, the scientiﬁc community, medical professionals, healthcare managers,
and patients.
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We currently live in a scientiﬁc context where great
discoveries, especially in medicine, are not as common as
earlier say 19th or early 20th century. Despite increasing
pharmaceutical R&D efforts, times, costs, and spending,
these efforts are not being reﬂected in the numbers of new
drugs being brought to the market.1 It is as a matter of fact,
widely reported that there has been a decline in the rate of
development of new drugs over past several decades.2,4 Not
only in new drug or disease discovery, almost everything we
know today about etiology of diseases was discovered way
back. The 2nd half of the twentieth century belonged to
pathogenesis, to clarify the molecular mechanisms and
possible new associations (more subtle) between exposure
and disease. Herein, case reports played a stellar role,
focusing on rare, unusual, new, and/or unknown diseases,
as well as change the natural history of a particular disease,
in addition to reports on new treatments, both medical &
surgical and complications associated with them. A case in
example, 1st successful CABG procedure was performed by
Rene Favaloro of the Cleveland Clinic in 1968. Favaloro's
report ﬁred the imagination of many surgeons who started
operating initially, on stable patients but as skill was
acquired on ever-sicker patients, and even during MI.5 By1977, cardiac surgeons were performing 100,000 bypass
procedures per year based only on case reports with no
single trial available, based only on the logic of the
procedure which was self-evident, ‘‘you have a plugged
vessel, you bypass the plug, and you ﬁx the problem, end of
story.’’ Like CABG, PCI rates also went from zero to 100,000
procedures in no time with no clinical trial: based just on the
logic of the procedure and patients' reports of how much
better they felt. While this kind of practice may also not be
justiﬁed, it is indeed reasonable that case reports be
considered useful tools in generating hypotheses triggering
conducting observational studies such as cohort, case-
control, and cross as well as experimental studies and
clinical trials, according to the nature of the case presented
in the report (basic as well as clinical).
2. The switch from case reports to original
studies/trials
Knowledge about anything can only be gained by two ways.
One way is by searching for similitude or resemblances
(integration) so that an entity is observed in entirety of process
and then its similarities to other already known process
identiﬁed a process that happens when a single case or a group
of cases is studied over a period of time.6 Finding similarities
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The limitation of this technique is that some false assump-
tions may be made based on assumed similarities, which may
really not exist as a matter of fact. This method of gaining
information essentially relies on intuition. The other way to
gain knowledge is that by comparison (differentiation), where
two processes are compared and the differences brought out.
This is the process followed in original studies or trials where a
natural history of disease may be compared with health or a
treatment modality is compared with a placebo or even
another treatment modality. The process gives accurate
information but it has several limitations as well.
1. The number of subjects required to give a meaningful result
may be huge especially if expected difference is small –
some trials requiring 1000s or even 100,000s of subjects.
2. The cost and logistics involved may be huge.
3. However, the biggest limitation is perhaps that the results
are applicable only in that limited context. For example,
Newtonian physics is applicable only on the surface of
earth and it goes completely haywire when this context is
lost, for example, in space where only Quantum Physics
works. In other words, the results may not be widely
applicable to Real World Scenario but are speciﬁc to trail
settings and if one has to apply them in real world setting,
some degree of intuition (rather than pure evidence) is
indeed required.
Unfortunately, after the advent of so-called evidence-based
medicine in the late 1980s, the descriptive studies lost favor
and have been considered by the academic community as a
kind of evidence of lower hierarchy in relation to RCTs. Not
surprisingly, the number of published case reports started
declining; for example, in the British Medical Journal, there were
149 case reports in 1990, but only 37 in 2005.7
3. What is the value of case reports in
medicine?
Historically, case reports have proven extremely valuable to
clinicians faced with new diseases, new investigations, and new
therapies. But faced with objectivity and exactitude, many
researchers (evidence based) argue that the obscure nature of
many case reports makes them of little value to the average
researcher. Not only that they are rarely considered for
development of guidelines where randomized clinical trials
(RCTs) ‘‘rule the roost’’, the fact that these guidelines may be
completely deﬁcient in certain areas (where the RCT was not
conducted for several reasons) does seem to bother anybody at
all.8 These guidelines value measurable, reproducible proof
(evidence) much more than individual experience. Not surpris-
ingly, case reports typically receive fewer citations than research
articles, putting them in danger of being phased out from
journals where citation data rules and where ‘‘impact factor’’ is
the material God. However, leaving aside impact factor, there are
several advantages to the practicing physician. They may:
1. Serve as the initial scientiﬁc material for any new disease,
diagnosis, or even treatment (a value to even clinical
researcher).2. They are very useful tools of information for busy
practitioners, providing them elements that undoubtedly
assist in the care of their patients. Reading the details of the
reports certainly update their knowledge as well as ability to
treat because these cases are real world patients (and not
ideal, artiﬁcial study setting), which have clinical details
much in common to their own patients.
3. They have an important role in medical education, i.e. the
training of medical students and residents of all clinical
areas of medicine, helping them learn new techniques, and
gain skills of treating intriguing case comprehensively.
4. Aid in gaining professional experience as a featured
element in medical decision making, especially considering
the safety of the patient and the proposed treatment, as well
as the natural history of the disease.
4. Conclusions
Thus, even though many will not agree with our decision to
have a special supplement focused on case reports, ‘‘this is a
retrograde step,’’ they might say, we sincerely believe that
dedicating an entire issue to case reports will ensure that these
valuable stories will be told, rare pathologies and new diseases
discovered but more importantly unusual presentations of a
common disease elucidated. Even unique and speciﬁc outlier
case report can be valuable to both researchers and clinicians –
signaling adverse drug interactions or symptoms of disease
that may be overlooked otherwise. Finally, value of case
reports in describing new procedural techniques can never be
emphasized. Many of us (who practice intervention cardiolo-
gy) will fondly remember how we used to read a new (then)
technique, be it of PTMC or retrograde BMV from Catheteriza-
tion and Cardiovascular Diagnosis, as it was known then.
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